Metformin hydrochloride-loaded nanoparticles were successfully i.v. administered in mice causing no adverse effects on the major organs [15], which may be used as an administration route for the treatment of polycystic ovary syndrome to increase insulin sensitivity and overcome insulin resistance in the ovaries [16,17]. Here, INS is linked to polycystic ovary syndrome.